| __timestamp | Ligand Pharmaceuticals Incorporated | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 9136000 | 520990000000 |
| Thursday, January 1, 2015 | 5807000 | 535405000000 |
| Friday, January 1, 2016 | 5571000 | 558755000000 |
| Sunday, January 1, 2017 | 5366000 | 495921000000 |
| Monday, January 1, 2018 | 6337000 | 659690000000 |
| Tuesday, January 1, 2019 | 11347000 | 1089764000000 |
| Wednesday, January 1, 2020 | 30419000 | 994308000000 |
| Friday, January 1, 2021 | 62176000 | 1106846000000 |
| Saturday, January 1, 2022 | 52827000 | 1244072000000 |
| Sunday, January 1, 2023 | 35049000 | 1431505000000 |
| Monday, January 1, 2024 | 1431505000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated present a fascinating study in contrasts. Over the past decade, Takeda's cost of revenue has surged by approximately 175%, peaking at 1.43 trillion yen in 2023. This reflects its expansive global operations and significant investments in research and development. In contrast, Ligand Pharmaceuticals, a smaller player, has seen its cost of revenue grow by nearly 500% from 2014 to 2023, reaching 35 million dollars. This sharp increase highlights Ligand's strategic shifts and growing market presence. However, the data for 2024 is incomplete, leaving room for speculation on future trends. As these companies navigate the complexities of the pharmaceutical landscape, their cost of revenue trends offer valuable insights into their operational strategies and market positioning.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Cytokinetics, Incorporated
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Ligand Pharmaceuticals Incorporated
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Catalent, Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Ligand Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost of Revenue: Key Insights for Alkermes plc and Ligand Pharmaceuticals Incorporated
Cost of Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Geron Corporation